1. Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
    Filipa Martins et al, 2020, Biomolecules CrossRef
  2. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
    Karina Biserova et al, 2021, Cells CrossRef
  3. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
    Marton Tompa et al, 2018, NeuroMolecular Medicine CrossRef
  4. To be Wild or Mutant: Role of Isocitrate Dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in Gliomagenesis and Treatment Outcome in Glioma
    Bharathan Bhavya et al, 2020, Cellular and Molecular Neurobiology CrossRef
  5. Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes?
    Anthony Patrizz et al, 2021, Journal of Neuro-Oncology CrossRef
  6. Lentiviral Vectors as Tools for the Study and Treatment of Glioblastoma
    Claudia Del Vecchio et al, 2019, Cancers CrossRef
  7. IDH1R132H Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells
    Geon-Hee Kim et al, 2019, International Journal of Molecular Sciences CrossRef
  8. In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs
    Safura Pournajaf et al, 2024, Reviews in the Neurosciences CrossRef
  9. Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification
    Alexandre Vallée et al, 2021, Biomedicines CrossRef
  10. Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
    Dandan Fan et al, 2021, OncoImmunology CrossRef